• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Pro-Pharmaceuticals to Present Corporate Update at Russ Trading Investor Meeting in Tempe, Arizona, and Red Chip Small Cap Conference in Scottsdale

Posted on: Thursday, 31 January 2008, 09:00 CST

Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate therapeutic compounds, today announced that Theodore Zucconi, Ph.D., President, is scheduled to present a corporate update at a Russ Trading investor meeting on Wednesday, February 6th, at 1 pm, mountain time, at the Embassy Suites Hotel, 4400 South Rural Road, Tempe, Arizona. Russ Trading is a registered investment advisor and wealth management firm.

The Company is also scheduled to present at the Red Chip Small Cap Investor Conference to be held at the Four Seasons Resort in Scottsdale Arizona, on Thursday, February 7, at 1:45 pm, mountain time. For more than 15 years, Red Chip has been dedicated to "discovering tomorrow's blue chips today™."

Pro-Pharmaceuticals, Inc. -- Advancing Drugs Through Glycoscience®

Pro-Pharmaceuticals is engaged in the discovery, development and commercialization of targeted polysaccharides as therapeutics for advanced treatment of cancer, liver, microbial, inflammatory diseases, and viral infections. Initially, the product pipeline is principally focused on increasing the efficacy and decreasing the toxicity of approved chemotherapy drugs. The Company also is developing a series of novel carbohydrate compounds that demonstrated remission of liver fibrosis in animal models. The Company is headquartered in Newton, Mass. Additional information is available at www.pro-pharmaceuticals.com.

FORWARD LOOKING STATEMENTS: Any statements in this news release about future expectations, plans and prospects for the Company, including without limitation statements containing the words "believes,""anticipates,""plans,""expects," and similar expressions, constitute forward-looking statements as defined in the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in such statements. Readers should not place undue reliance on forward-looking statements.

More information about those risks and uncertainties is contained and discussed in the "Management Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" sections of the Company's most recent quarterly or annual report and in the Company's other reports filed with the Securities and Exchange Commission. The forward-looking statements represent the Company's views as of the date of this news release and should not be relied upon to represent the Company's views as of a subsequent date. While the Company anticipates that subsequent events may cause the Company's views to change, the Company disclaims any obligation to update such forward-looking statements.

Advancing Drugs Through Glycoscience is a registered trademark of Pro-Pharmaceuticals. Discovering tomorrow's blue chips today is a trademark of Red Chip.

Source: Business Wire

More News in this Category